AbstractPurpose: The treatment of hemodialysis access-induced ischemic steal syndrome is challenging. Despite promising early results with the distal revascularization-interval ligation (DRIL) procedure, the operation has not been widely adopted because of concerns about its complexity and long-term efficacy. The purpose of this report was to determine the efficacy and durability of the DRIL procedure in relieving hand ischemia and in maintaining access patency in the setting of hemodialysis access-induced ischemia. Methods: A retrospective review was performed of all patients who underwent the DRIL procedure for access-induced ischemia. Demographic information was compiled, as were data regarding access and bypass patency, limb salvage, an...
AbstractTreatment of dialysis access-related hand ischaemia with preservation of the access remains ...
Distal hypoperfusion ischemic syndrome (DHIS), commonly referred to as hand ischemia or 'steal' afte...
The DRIL procedure first described in 1988 has long been considered the preferred treatment for arte...
BackgroundArterial steal syndrome after angioaccess surgery can lead to potentially devastating comp...
AbstractPurpose: Traditional options for treating ischemic steal syndrome related to a functioning d...
Access induced ischemia is an uncommon but devastating complication for patients maintained on hemod...
Dialysis access-related ischemic steal syndrome is a well-recognized dialysis access complication. W...
ObjectiveThe treatment goals of access-related hand ischemia (ARHI) are to reverse symptoms and salv...
BackgroundThe distal revascularization and interval ligation (DRIL) procedure has evolved as the opt...
Patients diagnosed with steal syndrome after hemodialysis access surgery have a few options for symp...
Distal revascularization and interval ligation (DRIL) is considered a useful option to relieve haemo...
Background: The reduction in distal arterial flow following arteriovenous fistula (AVF) creation can...
Objective: Vascular access-induced ischemia remains a rare but significant complication of arteri...
Objectives: Hemodialysis access induced distal ischemia (HAIDI) is not a rare complication of hemodi...
The distal revascularization and interval ligation procedure is commonly performed for steal syndrom...
AbstractTreatment of dialysis access-related hand ischaemia with preservation of the access remains ...
Distal hypoperfusion ischemic syndrome (DHIS), commonly referred to as hand ischemia or 'steal' afte...
The DRIL procedure first described in 1988 has long been considered the preferred treatment for arte...
BackgroundArterial steal syndrome after angioaccess surgery can lead to potentially devastating comp...
AbstractPurpose: Traditional options for treating ischemic steal syndrome related to a functioning d...
Access induced ischemia is an uncommon but devastating complication for patients maintained on hemod...
Dialysis access-related ischemic steal syndrome is a well-recognized dialysis access complication. W...
ObjectiveThe treatment goals of access-related hand ischemia (ARHI) are to reverse symptoms and salv...
BackgroundThe distal revascularization and interval ligation (DRIL) procedure has evolved as the opt...
Patients diagnosed with steal syndrome after hemodialysis access surgery have a few options for symp...
Distal revascularization and interval ligation (DRIL) is considered a useful option to relieve haemo...
Background: The reduction in distal arterial flow following arteriovenous fistula (AVF) creation can...
Objective: Vascular access-induced ischemia remains a rare but significant complication of arteri...
Objectives: Hemodialysis access induced distal ischemia (HAIDI) is not a rare complication of hemodi...
The distal revascularization and interval ligation procedure is commonly performed for steal syndrom...
AbstractTreatment of dialysis access-related hand ischaemia with preservation of the access remains ...
Distal hypoperfusion ischemic syndrome (DHIS), commonly referred to as hand ischemia or 'steal' afte...
The DRIL procedure first described in 1988 has long been considered the preferred treatment for arte...